Features Screener Stocks Charts
Sign In Sign Up

Novartis Income Statement

NSE:NOVARTIND | PHARMACEUTICALS

Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.

View Plans

2-year NOVARTIND income statement snapshot

Hover the chart icon for YoY change.

FY 2024 - FY 2025
Item Chart 2024 2025
Revenue 3.35B 3.56B
Cost of Revenue -1.80B -1.95B
Gross Profit 1.55B 1.61B
Sales, General & Admin -229.60M -187.20M
Operating Income 823.70M 967.30M
Profit Before Tax 1.23B 1.30B
Net Income 851.90M 1.01B
Diluted Shares 24.69M 24.69M
Diluted EPS 34.50 40.87

Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹). EPS is earnings per share.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025